This metabolic switch, dependent on the active axis PI3K-AKT, a part of the receptor tyrosine kinase/PI3K/AKT/mammalian target of rapamycin (RTK/PI3K/AKT/mTOR) signaling pathway, accelerates tumor proliferation and contributes to its aggressiveness [105]. Here, AKT1 is linked to neoplasm.